e.g. mhealth
Search Results (1 to 5 of 5 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 2 JMIR Dermatology
- 1 JMIR Medical Education
- 1 JMIR Medical Informatics
- 1 JMIR Research Protocols
- 0 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 JMIR Formative Research
- 0 Journal of Participatory Medicine
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Cutaneous Atrophy Following Corticosteroid Injections for Tendonitis: Report of Two Cases
Common adverse reactions to corticosteroid injections include atrophy, depigmentation, and cellulitis [1]. Skin depigmentation is a well-recognized adverse effect of corticosteroid injections, but atrophy is underrecognized. Atrophy typically manifests 2-4 months following the injection but may be delayed up to a year [2].
JMIR Dermatol 2025;8:e67921
Download Citation: END BibTex RIS
A Roadmap for Using Causal Inference and Machine Learning to Personalize Asthma Medication Selection
Inhaled corticosteroid (ICS) is a mainstay treatment for controlling asthma and preventing exacerbations in patients with persistent asthma [4] accounting for over 60% of people with asthma [5,6].
JMIR Med Inform 2024;12:e56572
Download Citation: END BibTex RIS
Reference 6: Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in childrencorticosteroid
JMIR Dermatol 2024;7:e46580
Download Citation: END BibTex RIS
In these dexamethasone-unresponsive patients with COVID-19, corticosteroid therapy is sometimes escalated to a much higher dose. However, large heterogeneity in the type, timing, and dosing of escalated corticosteroid therapy exists [11]. High-dose corticosteroids are mainly administered during the late phase of the clinical course and in patients with the most severe disease, while earlier administration could be beneficial in preventing disease progression.
JMIR Res Protoc 2023;12:e48183
Download Citation: END BibTex RIS
When the symptoms are persistent, the recommended treatment for allergic rhinitis consists of administration of intranasal corticosteroid sprays [7-9]. It is important to administer the nasal spray in the correct technical manner. A recent study has shown that only 6% of the patients used the correct administration technique of intranasal corticosteroid sprays as described in the patient information leaflet [10].
JMIR Med Educ 2020;6(2):e23668
Download Citation: END BibTex RIS